Procept BioRobotics CorpPRCT
Price$17.02Intrinsic value$94.92458% above price

Outlook & Key Dates

Estimates, guidance, catalysts, and upcoming events

Analyst Estimates Learn more →
5-Yr Fwd EPS Growth
22.3%projected annual EPS growth
As of 27 Aug 2026
Analyst Coverage
11analysts covering
Consensus: NeutralAs of 18 Aug 2026
FY Revenue (est.)
$395.4Mnext fiscal year
As of 18 Aug 2026
FY EPS (est.)
-$1.68next fiscal year
As of 18 Aug 2026
Monitoring Framework
Key Performance Indicators
Quarterly Revenue Quarterly83.1MTarget: 390000000 to 410000000
U.S. Quarterly Procedure Volume Quarterly12.2KTarget: 39% to 48% annual growth
Global Installed Base Quarterly971.0
Watch Items
  • Commercial Strategy and Sales Force Restructuring
  • WATER IV Prostate Cancer Trial CompletionTrigger: Completion of all procedures expected by mid-2026
Sign in / Sign up to read more

Research as of 20 Jun 2026

AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.